Cilostazol Improves Long-Term Patency after Percutaneous Transluminal Angioplasty in Hemodialysis Patients with Peripheral Artery Disease

Background and objectives: Peripheral artery disease (PAD) is common in patients on hemodialysis (HD). Recently, cilostazol has been reported to reduce target lesion revascularization (TLR) after percutaneous transluminal angioplasty (PTA) for PAD in the general population. This study aimed to clari...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ishii, Hideki, Kumada, Yoshitake, Toriyama, Takanobu, Aoyama, Toru, Takahashi, Hiroshi, Yamada, Shigeki, Yasuda, Yoshinari, Yuzawa, Yukio, Maruyama, Shoichi, Matsuo, Seiichi, Matsubara, Tatsuaki, Murohara, Toyoaki
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2008
Assuntos:
Clinical Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2440261/
https://ncbi.nlm.nih.gov/pubmed/18322041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.05761207
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados